Researchers Develop DNA Repair Gene-Based Score to Predict Ovarian Cancer Outcomes After Chemotherapy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from the Dana-Farber Cancer Institute have come up with a risk score based on the expression of almost two-dozen DNA repair-related genes that they say can help predict ovarian cancer outcomes following platinum-based chemotherapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.